Established in December, 2006, with total investment of $ 50,000,000, Kanghong Sagent (Chengdu) Pharmaceuticals, Inc is equally invested by Chengdu Kanghong Science and Technology Industrial (group) Co., Ltd and American Sagent Pharmaceuticals Inc. The company is located at Export Process Park, Western Park of Chengdu High and New Technical Development Area, covering an area of 170 mu, with the first stage construction area of 50,000 m². 7 small squirt production lines and 2 jelly powder needle production lines will be built as per American GMP standard, and they will pass Chinese SFDA and American FDA attestation. The main product include tumor, anti-infection and common clinic inject medicine, and anticipated annual production scale is 300 million product units, annual production value $ 1 billion. Product will be sold to global markets all over the world.